These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30337420)

  • 21. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent.
    Desjardins N; Jamoulle O; Taddeo D; Stheneur C
    J Adolesc Health; 2015 Nov; 57(5):565-7. PubMed ID: 26372366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline.
    Lapoint J; Meyer S; Yu CK; Koenig KL; Lev R; Thihalolipavan S; Staats K; Kahn CA
    West J Emerg Med; 2018 Mar; 19(2):380-386. PubMed ID: 29560069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BET 2: Antiemetic use in paediatric sedation with ketamine.
    Dunlop L; Hall D
    Emerg Med J; 2018 Aug; 35(8):524-525. PubMed ID: 30030238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Best evidence topic reports. Metoclopramide versus placebo with opioid.
    Alsalim W; Leung WC; Butler J
    Emerg Med J; 2004 May; 21(3):334-5. PubMed ID: 15107376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cannabinoid hyperemesis].
    Alfonso Moreno V; Ojesa F; Moreno-Osset E
    Gastroenterol Hepatol; 2006; 29(7):434-5. PubMed ID: 16938265
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department.
    Kum V; Bell A; Fang W; VanWert E
    Am J Emerg Med; 2021 Nov; 49():343-351. PubMed ID: 34242945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department.
    Lee A; Coralic Z
    Ann Pharmacother; 2022 Feb; 56(2):151-154. PubMed ID: 33998315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid Hyperemesis Syndrome During Pregnancy: A Case Report.
    Andrews KH; Bracero LA
    J Reprod Med; 2015; 60(9-10):430-2. PubMed ID: 26592070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic.
    Lu ML; Agito MD
    Cleve Clin J Med; 2015 Jul; 82(7):429-34. PubMed ID: 26185942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BET 2: prophylactic antiemetic use in immobilised adult trauma patients.
    Gouldthorpe C; Clarke J; Metcalfe NH
    Emerg Med J; 2014 Aug; 31(8):693-4. PubMed ID: 25022920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid hyperemesis syndrome: A case study and discussion.
    Creedon ES; Maloy MK; DelloStritto RA
    J Am Assoc Nurse Pract; 2020 Mar; 32(3):269-276. PubMed ID: 31274681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy.
    Schmid SM; Lapaire O; Huang DJ; Jürgens FE; Güth U
    Arch Gynecol Obstet; 2011 Nov; 284(5):1095-7. PubMed ID: 21170540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid hyperemesis syndrome.
    Heise L
    Adv Emerg Nurs J; 2015; 37(2):95-101. PubMed ID: 25929220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
    Moussa G; Genest M; Villeneuve E; Wang JJ
    Ann Emerg Med; 2021 May; 77(5):555. PubMed ID: 33902836
    [No Abstract]   [Full Text] [Related]  

  • 35. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
    Nourbakhsh M; Miller A; Gofton J; Jones G; Adeagbo B
    J Forensic Sci; 2019 Jan; 64(1):270-274. PubMed ID: 29768651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network.
    Schreck B; Wagneur N; Caillet P; Gérardin M; Cholet J; Spadari M; Authier N; Tournebize J; Gaillard M; Serre A; Carton L; Pain S; Jolliet P; Victorri-Vigneau C
    Drug Alcohol Depend; 2018 Jan; 182():27-32. PubMed ID: 29132050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
    Bajgoric S; Samra K; Chandrapalan S; Gautam N
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26698198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cannabinoid hyperemesis syndrome should be considered by recurrent vomiting].
    Nordholm-Carstensen A
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cannabinoid hyperemesis syndrome: about 6 cases].
    Bertolino J; Abdo L; Khau D; Meckenstock R; Sautereau N; Jean E; Greder-Belan A; Frances Y; Cabane J; Granel B
    Rev Med Interne; 2015 Oct; 36(10):694-7. PubMed ID: 25547957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?
    Richards JR
    Med Hypotheses; 2017 Jun; 103():90-95. PubMed ID: 28571820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.